Date published: 2025-10-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

PHIP Inhibitors

PHIP inhibitors belong to a class of chemical compounds designed to target the protein PHIP, which stands for Pleckstrin homology domain-interacting protein. PHIP is a multi-domain protein that plays a crucial role in various cellular processes, particularly in the regulation of signal transduction pathways. This protein is known for its interactions with other signaling molecules and its involvement in the modulation of cellular responses to various external stimuli. PHIP contains several functional domains, including a pleckstrin homology (PH) domain, which is responsible for its binding to certain lipids, and proline-rich regions that interact with other signaling proteins. By inhibiting PHIP, these compounds can potentially disrupt the normal functioning of signaling pathways and cellular responses, influencing various biological processes.

PHIP inhibitors may work through different mechanisms, depending on their specific chemical structures. Some inhibitors may bind directly to the PH domain of PHIP, preventing its interaction with lipid molecules or other binding partners. Others may interfere with the proline-rich regions of PHIP, disrupting its associations with downstream signaling molecules. Through these mechanisms, PHIP inhibitors have the potential to modulate signal transduction pathways and impact cellular processes such as cell growth, proliferation, and differentiation. Ongoing research aims to uncover the precise mechanisms and downstream effects of PHIP inhibition, shedding light on the importance of this protein in cellular biology.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$112.00
$163.00
$928.00
19
(1)

A MEK inhibitor that can indirectly affect PHIP function by modulating the MAPK/ERK pathway, which is involved in cellular proliferation and survival.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$115.00
$415.00
11
(1)

A BRAF inhibitor that impacts the MAPK/ERK pathway, potentially influencing PHIP-related signaling in cells with BRAF mutations.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$128.00
$638.00
7
(1)

An mTOR inhibitor that can affect PHIP function by modulating cellular growth, proliferation, and survival pathways.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Another mTOR inhibitor, similar to Everolimus, impacting pathways relevant to PHIP's role in cell growth and survival.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

A multi-kinase inhibitor that affects various pathways including RAF kinases, potentially influencing PHIP activity indirectly.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$150.00
$920.00
5
(0)

A receptor tyrosine kinase inhibitor, impacting pathways in angiogenesis and cell proliferation that may indirectly affect PHIP.

Palbociclib

571190-30-2sc-507366
50 mg
$315.00
(0)

A CDK4/6 inhibitor, potentially influencing cell cycle progression and thus indirectly affecting PHIP function.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

A proteasome inhibitor that can affect multiple cellular pathways, potentially influencing PHIP function indirectly.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

A Src family kinase inhibitor, could influence signaling pathways related to PHIP activity.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$127.00
$178.00
2
(1)

A multi-kinase inhibitor targeting vascular endothelial growth factor receptors, potentially impacting PHIP indirectly.